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Letters
Different, Not Biased
To the Editor:
In their paper “Bias in using family history as a risk factor in 
case-control studies of disease/ ’1 Khoury and Handers have 
shown that the odds ratio (OR) for a positive family history, 
calculated from viewing the data from a case-control design 
perspective (that is, exposure =  disease in one or more rela­
tives), is a function of the number of relatives of cases and 
controls. They compared this measure with the relatives’ risk 
ratio (RRR), a measure of familial aggregation calculated from 
viewing the data as a cohort study of relatives (that is, exposure 
=  case/control status of proband), and showed that the two 
estimates differed under varying conditions.
They have, however, interpreted the difference between OR 
and RRR as representing “bias”—note the first word of their 
title. In particular, they claim that the OR is an overestimate. 
In my opinion, this is an incorrect use of the term bias. 
(Epidemiologists often use the word “bias” to reflect design 
issues, such as differential recall, but that does not appear to be 
the concept being alluded to by Khoury and Flanders.)
Last2 defines bias as “any effect at any stage of investigation 
or inference tending to produce results that depart systemati­
cally from the true values.” In statistical parlance, an estimator, 
§, is biased if its expected (average) value differs from that of 
the population parameter it is purportedly estimating, 0. In the 
situation under discussion, there are two estimators directed at 
different entities; 0] =  OR is estimating the risk to an individ­
ual associated with the existence of one or more affected rela­
tives (fy), whereas 02 = RRR is estimating the risk to an 
individual associated with just one relative being affected (02)* 
OR is only “biased” if it is thought to be an estimator of d2, 
which it clearly is not (unless there is always exactly one 
relative in the exposure set). Part of the problem probably lies 
with the authors not differentiating between estimators and 
parameters— an unfortunate and common practice in epidemic 
ology. The issue of any bias per se of these two estimators was 
not addressed in the paper. It is well known that the sample 
odds ratio is an unbiased estimator of the population risk ratio, 
rate ratio, or odds ratio, depending on the method used to 
sample controls.
Pearson’s and Kendall’s correlation coefficients are both 
measures of association, but we do not talk of one of them as 
being a biased estimator because it gives different values from 
the other. Similarly, OR and RRR are both measures of famil- 
ial aggregation for a disease, and there is no compulsion that 
the estimators should be equivalent, especially when one looks 
closely at their definitions.
The RRR may well be preferred to OR for a number of 
reasons. (Note, however, that the data may not be in a form 
from which RRR can be calculated, and that, as its standard 
error estimates are typically based on the assumption of inde- 
pendence within exposure sets, they will be underestimates by 
an amount depending on the strength of familial aggregation.) 
RRR attempts to make more use of the information in the data, 
and the parameter it estimates has an unambiguous meaning, 
whereas OR is difficult to interpret if it is calculated from a 
sample of (case and control) families of varying sizes. It is not
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justified, however, to consider that an estimator based on using 
family history as a risk factor in case-control studies is biased, in 
either the statistical or epidemiologic sense of the word.
John L. Hopper
Australian National Health and 
Medical Research Council Twin Registry,
Department of Public Health and Community Medicine,
University of Melbourne, 200 Berkeley Street,
Carlton, Victoria 3053, Australia
(address for correspondence)
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The Authors Reply:
While Dr. Hopper’s point is well taken, the issue is mostly 
semantic. In many epidemiologic studies, positive family his­
tory odds ratio (OR) is used to estimate relatives’ risk ratio 
(RRR). We have shown in our paper that OR is indeed a 
biased estimator of RRR. Family history OR, however, may be 
a consistent estimator of a parameter of familial aggregation, 
but this parameter is a complex function of the number of case 
and control relatives, their age distribution, and age at onset of 
disease. The whole point of our article is to illustrate how using 
family history OR in case-control studies can lead to varying 
and often overinflated measurement of familial aggregation, 
even when there is no case-control difference with respect to 
family size and age distribution. Most importantly, because 
family history is not a personal attribute or characteristic such 
as smoking or alcohol use, odds ratios derived from using family 
history cannot be compared across different studies and popu­
lations. We are glad that Dr. Hopper agrees with us that RRR 
is preferable to whatever parameter positive family history OR 
may be estimating. We also agree with Hopper that most 
case-control data may not be in a form from which RRR can be 
estimated. The latter point is more of a reason to caution 
epidemiologists against using positive family history as an easy 
and convenient way to measure familial aggregation,
Muin J, Khoury
Birth Defects and Genetic Diseases Branch,
Centers for Disease Control and Prevention,
MS F45, 1600 Clifton Road, Atlanta, GA 30333 
(address for correspondence)
W* Dana Flanders
Rollins School of Public Health, Emory University,
Atlanta, GA
Parental Age and Breast Cancer Mortality
To the Editor:
Holmberg et al1 found a higher relative hazard for death from
breast cancer of 1,30 (95% confidence interval =  0*85-1.98)
330
Epidemiology May 1996, Volume 7 Number 3 MATCHING IN OBSERVATIONAL STUDIES 331
in daughters bom to mothers age 45 years or older, compared 
with mothers under the age of 20  years. Their finding was in 
accord with at least five other studies and, according to the 
authors, substantiates the claims2 for intrauterine influences of 
endogenous pregnancy estrogens on later breast cancer risk. 
They were embarrassed, however, by the absence of a clear 
linear trend for higher risk with increasing age of the mother at 
birth.
Close inspection into the maternal age categories after full 
adjustment for known confounders (that is, age at menarche, 
age at first pregnancy, and parity), however, indicates that the 
higher risks were present not only at the end, but at both 
extremes of reproductive age [that is, adolescence ( < 2 0  years 
of age) and premenopause (2:45 years of age)]. Thompson and 
Janerich3 also found young maternal age at birth to be a risk 
factor. A U-shaped relation with maternal age is well estab- 
lished for menstrual and hormonal disturbances4 and, thus, for 
optimum maturation of the oocyte. A higher risk for breast 
cancer for twins5 also shifts our attention from intrauterine to 
intratubal or even intrafollicular influences. As in the case of 
clear cell adenocarcinoma,6 overripeness ovopathy should be 
considered as an alternate causal trigger for carcinogenesis, as 
pointed out by Witschi7: “The persistence of an embryonic 
appearance of the cells, designated as aplasia or progressive 
failure of cells to differentiate, is the most constant effect 
produced by overripeness (of the egg); if combined with con­
siderable growth, it leads to the formation of neopliwms.1’
Some anthropometric and reproductive characteristics, such 
as early menarche, late menopause, and menstrual distur­
bances, are related to breast cancer and have been shown to be 
connected with overripeness ovopathy.8 This factor, in concert 
with other components of the causal pathway, can be put to 
the test by examining the hazard for breast cancer in the 
younger maternal age categories and the other high-risk con­
ceptions (for example, “spring” and “autumn11 conceptions, 
short and long interpregnancy intervals, endocrinologic dis­
eases, and so on).9
Piet Hein Jongbloet 
Carla van Gils 
Huub Straatman
Department of Epidemiology, University of Nijmegen, 
P.O. Box 9101, 6500 HB Nijmegen, the Netherlands 
(address correspondence to: Piet Hein Jongbloet)
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Software for Optimal Matching in 
Observational Studies
To the Editor:
Individual matching can be done using either greedy or 
optimal algorithms. The latter method has the advantage of 
finding the set of case-control matches that are closest among 
all possible pairings. This method was recently illustrated in a 
report by Cologne and Shibata,1 in which they encouraged the 
implementation of optimal matching routines in major statis­
tical computer packages. Here, we describe a SAS macro, 
%match, written to implement the optimal matching algo­
rithm of Rosenbaum.2,3 The macro can also perform matching 
within risk sets as defined within nested case-control studies, 
and it can be used in matched cohort studies that match 
unexposed subjects to exposed subjects.
To determine which control is “best” for a particular case, it 
is necessary to provide some notation and a definition of 
distance between cases and potential controls.
Let
Xl ={x\
and
be the vector of p matching variables for the N  cases and 
M (S:N) potential controls, respectively. Let D {} =  “dis­
tance” between the tth case and the jth potential con­
trol Choices for include the Euclidean distance 
(using standardized X’s), Mahalanobis distance, the sum 
of the absolute (or squared) difference in the ranks of the 
X*s, or the absolute (or squared) difference in propensity 
or “balancing” scores.1,3
For this macro, we define the distance as:
Dij =  2 l 4 - 4 I  -Wk.
fc-i
where W k is an arbitrary nonnegative weight associated 
with matching variable (it).
This definition allows considerable flexibility. Instead 
of the actual X’s, standardized X*s, a propensity score, or 
the ranks of the X’s could be used. In addition, the 
weights allow the user considerable flexibility to modify 
the distance definition.
The optimal matching algorithm is designed to min- 
imize the total over the set of all possible matchings.3 
“Greedy” algorithms, on the other hand, involve pro­
ceeding sequentially through the list of cases, selecting 
the best available control at each step. Our experience2 
and that of Rosenbaum3 suggest that optimal matching 
produces matched sets that are 5-10% “closer” than 
those defined with the greedy algorithm.
The SAS macro %match was written to provide an 
efficient and reproducible method of matching cases to
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